Swiss biotech CSO/CMO meeting
Wednesday, September 2, 2026, 9:30 - 17:00
Fondation ISREC, Bâtiment AGORA, Rue du Bugnon 25A, 1005 Lausanne
We are delighted to invite you to our first informal peer-to-peer meeting for chief scientific and chief medical officers.
Join us for a program designed to guide you through the critical stages of drug development. Experienced scientific and medical leaders share practical insights, real-world lessons, and actionable strategies across both non-clinical and clinical development phases in an informal setting.
Through expert talks and interactive discussions, the meeting fosters collaboration and strengthens excellence across the Swiss biotech ecosystem.
Help shape a relevant and impactful program—share your input during registration.
Join us at the SITC EU Immuno-Oncology Drug Development Summit
After the CSO/CMO meeting, continue at the SITC EU Immuno-Oncology Drug Development Summit at the same venue on September 3, 2026. All CSO/CMO meeting participants, as well as Swiss Biotech Association members benefit from a 10% discount.
Preliminary program
More program details and speakers will be announced in due course…
9:30
Welcome coffee
10:00
From Leads to Development – presentation
Key insights and strategies to move from research to non-clinical development
Madiha Derouazi, CEO SwitchKine & Michael Altorfer, CEO Swiss Biotech Association
Roundtable with Chief Scientific Officers on key learnings and common pitfalls
12:30
Networking lunch
13:30
In vivo activities and toxicology studies: A comparison of Swiss, EU and China methods
14:30
Comparison of the regulatory frameworks in Switzerland and the European Union for first-in-human / phase 1
15:00
Coffee break
15:30
Where to best run clinical trials: Considerations across the regions
16:30
Roundtable with Chief Medical Officers on key learnings and common pitfalls